- 2025-07-28 09:45Ablukast (Ro23-3544) 96566-25-5
- 2025-07-28 09:45CYM-5442 1094042-01-9
- 2025-07-28 09:45Pranlukast 103177-37-3
- 2025-07-28 09:45CYM-50308 1345858-76-5
- 2025-07-28 09:45Zafirlukast (ICI 204219) 107753-78-6
- 2025-07-28 09:44CAY10734 635701-59-6
- 2025-07-28 09:44Lipoic Acid [R-(+)-Thioctic acid] 1200-22-2
- 2025-07-28 09:44MONTELUKAST SODIUM (MK0476) 151767-02-1
- 2025-07-28 09:44C16-Sphingosine-1-phosphate 709026-60-8
- 2025-07-28 09:44Montelukast Dicyclohexylamine 577953-88-9
- 2025-07-28 09:44BMS-986104 1622180-31-7
- 2025-07-28 09:44Olsalazine Sodium (CJ-91B) 6054-98-4
- 2025-07-28 09:44BMS-986020 1257213-50-5
- 2025-07-28 09:44AM095 sodium 1345614-59-6
- 2025-07-28 09:44γ-Linolenic acid ethyl ester (Ethyl γ-linolenate) 31450-14-3
- 2025-07-28 09:44AM095 free acid 1228690-36-5
- 2025-07-28 09:44Zafirlukast-d7 (Zafirlukast d7) 1217174-18-9
- 2025-07-28 09:44ACT-1016-0707 (LPA1 receptor antagonist 2) 2569467-78-1
- 2025-07-28 09:44Zafirlukast metabolite M1 219583-10-5
- 2025-07-28 09:44A6770 1331754-16-5
